Patent · US Active

Humanized mouse models of the FcRn recycling pathway

US12156517B1 · kind B1 · utility

0Cited by
5References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 25, 2022
Grant dateDec 3, 2024
Priority date
Expiry dateApr 20, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present disclosure provides improved humanized IgG1 FCRN mouse models for use, for example, in estimating serum half-life of therapeutic proteins such as monoclonal antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.